Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

DCEP regimen

A regimen consisting of dexamethasone, cyclophosphamide, etoposide, and cisplatin that may be used as a salvage regimen for relapsed and/or refractory plasma cell myeloma and/or as a mobilization regimen, followed by granulocyte colony-stimulating factor (G-CSF), for peripheral blood stem cell (PBSC) collection in plasma cell myeloma.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:dexamethasone-cyclophosphamide-etoposide-cisplatin
dexamethasone-Cytoxan-Vepesid-Platinol
dexamethasone/cyclophosphamide/etoposide/cisplatin
dexamethasone/cyclophosphamide/etoposide/cisplatin regimen
Abbreviation:DCEP
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search